BioCryst underwriters exercise options; stock offering to top $20M

Home › BioCryst underwriters exercise options; stock offering to top $20M

BioCryst Pharmaceuticals is well on its way to raising more than $20 million to support clinical development of its drug pipeline.

23.11
23.11	NEXT
23.11
23.11	(Rawlings)
23.11	DVD2
23.11
23.11	US Orig LP The Soul Searchers Salt Of ~
23.11	Switch SR SL LED 2
More »

je.st